Feedback / Questions
cebranopadol (TRN-228) - Tris Pharma
https://www.businesswire.com/news/home/20240903523518/en/Findings-Presented-at-PAINWeek-2024-Demonstrate-Tris-Pharma%E2%80%99s-Investigational-First-in-Class-Therapy-Cebranopadol-Provides-Potent-Prolonged-Pain-Relief-with-Improved-Safety-Over-Oxycodone
Sep 3, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next